MD3885G2 - Method for polyparasitosis complex treatment in cattle - Google Patents

Method for polyparasitosis complex treatment in cattle

Info

Publication number
MD3885G2
MD3885G2 MDA20080174A MD20080174A MD3885G2 MD 3885 G2 MD3885 G2 MD 3885G2 MD A20080174 A MDA20080174 A MD A20080174A MD 20080174 A MD20080174 A MD 20080174A MD 3885 G2 MD3885 G2 MD 3885G2
Authority
MD
Moldova
Prior art keywords
dose
body weight
polyparasitosis
cattle
complex treatment
Prior art date
Application number
MDA20080174A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3885F1 (en
Inventor
Олег КИХАЙ
Думитру ЕРХАН
Штефан РУСУ
Галина МЕЛЬНИК
Тудор АНГЕЛ
Original Assignee
Институт Зоологии Академии Наук Молдовы
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Зоологии Академии Наук Молдовы filed Critical Институт Зоологии Академии Наук Молдовы
Priority to MDA20080174A priority Critical patent/MD3885G2/en
Publication of MD3885F1 publication Critical patent/MD3885F1/en
Publication of MD3885G2 publication Critical patent/MD3885G2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to the veterinary medicine, namely to a method for polyparasitosis complex treatment to cattle.The method for polyparasitosis complex treatment to cattle includes administration of antiparasitic, antibacterial preparations and additionally of Umbelicen immunomodulator, which is administered subcutaneously in a dose of 0,05 ml/kg of body weight sevenfold with an interval of 5 days, at the same time the first three administrations are carried out before administration of antiparasitic and antibacterial preparations, and beginning with the 4-th administration concomitantly with the Umbelicen it is consecutively administered Brovitacoccid perorally in a dose of 1,5 g/10 kg of body weight during 5 days, 1% Ivomec subcutaneously in a dose of 1 ml/kg of body weight one day and Tylovet 200 intramuscularly in a dose of 0,025 g/kg of body weight during 5 days.
MDA20080174A 2008-06-26 2008-06-26 Method for polyparasitosis complex treatment in cattle MD3885G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080174A MD3885G2 (en) 2008-06-26 2008-06-26 Method for polyparasitosis complex treatment in cattle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080174A MD3885G2 (en) 2008-06-26 2008-06-26 Method for polyparasitosis complex treatment in cattle

Publications (2)

Publication Number Publication Date
MD3885F1 MD3885F1 (en) 2009-04-30
MD3885G2 true MD3885G2 (en) 2009-12-31

Family

ID=40901721

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080174A MD3885G2 (en) 2008-06-26 2008-06-26 Method for polyparasitosis complex treatment in cattle

Country Status (1)

Country Link
MD (1) MD3885G2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD80Z (en) * 2009-04-06 2010-04-30 Институт Зоологии Академии Наук Молдовы Method for prophylaxis and treatment of parasitoses in cattle
MD1013Z (en) * 2014-09-16 2016-10-31 Антон ЯТУСЕВИЧ Method for treating arachnoenthomoses and nematodoses in piglets and calves

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Петров Ю.Ф. Паразитоценозы и ассоциативные болезни сельскохозяйственных животных. Ленинград, 1988, с. 158-175 *

Also Published As

Publication number Publication date
MD3885F1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
NZ700182A (en) Parenteral formulations for administering macrolide antibiotics
MX2018006299A (en) Peptide analogs of alpha-melanocyte stimulating hormone.
MX2021009199A (en) Bi-ligand drug conjugate and use thereof.
CR20210368A (en) Combination of dextromethorphan and bupropion for treating depression
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
MX2021015543A (en) Pyrimidine derivative inhibiting growth of cancer cell and medicinal use thereof.
MX2011011058A (en) Selective ep4 receptor agonistic substance for treatment of cancer.
MX2022000430A (en) Administration of sting agonist and checkpoint inhibitors.
MX2013003523A (en) Low dose pharmaceutical composition comprising zanamivir.
WO2012044783A8 (en) Method of achieving a thymosin beta 4 concentration in a human patient
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
MD3885G2 (en) Method for polyparasitosis complex treatment in cattle
JOP20190019A1 (en) PHARMACEUTICAL COMPOSITION FOR TREATING GROWTH HORMONE DEFICIENCY CONTAINING hGH FUSION PROTEIN
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
WO2007139433A8 (en) Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application
MD3803G2 (en) Method of treating hyperkinesia of children
MD3226G2 (en) Process for spermatogenesis optimization to bulls-reproducers
MX2019001210A (en) Anticancer pharmaceutical composition.
RU2008150401A (en) METHOD FOR TREATING BABESIOSIS OF DOGS
NZ602655A (en) Preparation for the treatment of equine laminitis
JP2016017059A (en) Composition comprising antitumor prodrug
UA112614U (en) METHOD OF IMPROVEMENT OF LIPID PEROXIDAL OXIDISATION AND CORRECTION OF ANTI-OXIDANT PROTECTION OF BODY AND NON-BODY ORGANISM IN THE PROFILEZEL PROFILEZEL COMPLEX
UA97044C2 (en) Agent of antiviral and immunopotentiating activity, process for the preparation thereof and method for the treatment and prevention of infectious diseases
MD17Z (en) Method for treating stable anxious depressive states
MD3832G2 (en) Method for prophylaxis and treatment of sarcocystosis in cattle

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees